![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
Obesity
Drug Studies (QDIS Blog)
In response to commentary appearing in a recent issue of The Lancet about
a need for more long-term data on obesity drugs, including Xenical (orlistat),
Meridia (sibutramine) and Acomplia (rimonabant), Ed Vawter writes, "I tend
to agree, especially since they all seem to have the potential for serious side
effects which show up even with just short-term use. As I have said here many
times, they risk and reward need to be weighed for the use of any drug."
"Long-term safety data will likely be one of the primary topics for FDA reform this year from the Democrats in Congress, especially in the House of Representatives."
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct